Riverhead Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $791K | Hold |
6,271
| – | – | 0.03% | 553 |
|
|
2019
Q2 | $755K | Hold |
6,271
| – | – | 0.03% | 581 |
|
|
2019
Q1 | $549K | Buy |
6,271
+300
| +5% | +$26.3K | 0.02% | 664 |
|
|
2018
Q4 | $597K | Hold |
5,971
| – | – | 0.03% | 590 |
|
|
2018
Q3 | $684K | Buy |
5,971
+1,300
| +28% | +$149K | 0.02% | 616 |
|
|
2018
Q2 | $419K | Hold |
4,671
| – | – | 0.02% | 748 |
|
|
2018
Q1 | $342K | Hold |
4,671
| – | – | 0.01% | 821 |
|
|
2017
Q4 | $271K | Buy |
4,671
+700
| +18% | +$40.6K | 0.01% | 938 |
|
|
2017
Q3 | $178K | Buy |
3,971
+564
| +17% | +$25.3K | 0.01% | 1033 |
|
|
2017
Q2 | $135K | Buy |
3,407
+1,507
| +79% | +$59.7K | 0.01% | 1092 |
|
|
2017
Q1 | $77K | Buy |
1,900
+100
| +6% | +$4.05K | ﹤0.01% | 1097 |
|
|
2016
Q4 | $72K | Hold |
1,800
| – | – | ﹤0.01% | 1100 |
|
|
2016
Q3 | $65K | Sell |
1,800
-26,217
| -94% | -$947K | ﹤0.01% | 1081 |
|
|
2016
Q2 | $1.27M | Buy |
28,017
+18,792
| +204% | +$851K | 0.04% | 381 |
|
|
2016
Q1 | $323K | Sell |
9,225
-3,075
| -25% | -$108K | ﹤0.01% | 1081 |
|
|
2015
Q4 | $397K | Buy |
12,300
+8,700
| +242% | +$281K | 0.01% | 1004 |
|
|
2015
Q3 | $116K | Buy |
+3,600
| New | +$116K | ﹤0.01% | 1008 |
|